Notícias Eulerpool HLS Therapeutics

HLS Therapeutics Eulerpool-AFX

HLS Therapeutics Notícias de ações

HLS Therapeutics é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de HLS Therapeutics nós reunimos aqui.

• 2 de julho ·

  Yahoo
  HLS Therapeutics Announces the Sale of its XENPOZYME® Royalty Interest to DRI Healthcare Trust
• 8 de junho ·

  Yahoo
  HLS Therapeutics Reports Annual Meeting Results
• 5 de junho ·

  Yahoo
  Shareholders in HLS Therapeutics (TSE:HLS) are in the red if they invested three years ago
• 28 de maio ·

  Yahoo
  New Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine Treatment
• 9 de maio ·

  Yahoo
  An Intrinsic Calculation For HLS Therapeutics Inc. (TSE:HLS) Suggests It's 44% Undervalued
• 9 de maio ·

  Yahoo
  HLS Therapeutics Announces Q1 2024 Financial Results
• 25 de abril ·

  Yahoo
  HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call
• 9 de abril ·

  Yahoo
  HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
• 8 de abril ·

  Yahoo
  New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
• 17 de março ·

  Yahoo
  Earnings Release: Here's Why Analysts Cut Their HLS Therapeutics Inc. (TSE:HLS) Price Target To CA$6.57